Caxton Associates (New York)’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-7,976
| Closed | -$1.61M | – | 531 |
|
|
2023
Q1 | $1.61M | Buy |
+7,976
| New | +$1.61M | 0.24% | 71 |
|
|
2022
Q3 | – | Sell |
-1,555
| Closed | -$333K | – | 491 |
|
|
2022
Q2 | $333K | Buy |
+1,555
| New | +$333K | 0.03% | 336 |
|
|
2018
Q4 | – | Sell |
-2,293
| Closed | -$309K | – | 304 |
|
|
2018
Q3 | $309K | Buy |
+2,293
| New | +$309K | 0.02% | 274 |
|